NKG2D,

Anthony V Serritella1, Pablo Saenz-Lopez Larrocha2, Payal Dhar2

  • 1Department of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Biomedicines
|January 23, 2024
PubMed
概括

像sMIC这样的可溶性NKG2D配体基于癌症干细胞特性影响瘤形成. 一旦建立起来,sMIC会抑制抗瘤免疫力,支持其在癌症免疫治疗中的应用.